Abortion pills can be sold at US pharmacies, the Food and Drug Administration rules

Retail stores will now be able to sell abortion pills in the US for the first time, with the Food and Drug Administration (FDA) having made a regulatory change in a major move towards expanding access to abortion for more women.

Mifepristone, the first pill used in a two-drug regimen, will be available in retail shops and pharmacies that apply for certification to distribute the pill – and then and can be bought with a doctor’s prescription.

The FDA had first said it would be making those changes in December 2021 when it announced that it would relax some risk evaluation and mitigation strategies (REMS) on the pill, that had been in place since the agency approved it in 2000 and were lifted temporarily in 2021 due to the Covid-19 pandemic.

The changes included permanently removing restrictions on mail-order shipping of the pills.

The agency has finalised the changes after reviewing supplemental applications from Danco Laboratories and GenBioPro, the two companies that make the drug in the United States.

“Under the Mifepristone REMS Program, as modified, Mifeprex and it’s approved generic can be dispensed by certified pharmacies or by or under the supervision of a certified prescriber,” the agency said. Mifeprex is the brand name version of mifepristone.

The changes come after abortion access was sharply curtailed in the US by the Supreme Court’s decision to overturn the landmark Roe v Wade ruling and the state bans that followed.

Abortion rights activists say the pill has a long track record of being safe and effective, with no risk of overdose or addiction. In several countries, including India and Mexico, women can buy them without a prescription to induce abortion.

“Today’s news is a step in the right direction for health equity,” Planned Parenthood President Alexis McGill Johnson said in a statement.

“Being able to access your prescribed medication abortion through the mail or to pick it up in person from a pharmacy like any other prescription is a game changer for people trying to access basic health care,” Ms Johnson added.

Additional reporting by agencies